← Back to Patent Explorer
US3954663A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of Limulina lysate

Assignee: Aska Pharmaceutical Co Ltd
•
Filing: 1973-12-10
•
Granted: 1976-05-04
•
Expires: 1993-12-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process comprising extracting the blood of horseshoe crabs (Limulina) into an isotonic buffer solution containing an agent which inhibits the agglutination of amebocyte, separating the amebocyte from said solution, breaking the amebocyte, and recovering Limulina lysate, which is characterized in that methyl derivatives of xanthine such as theophyline, theobromine, or caffeine, or their salts, are used as the amebocyte's agglutination-inhibiting agent is disclosed.

Inventors

  • 👤 Masaaki Yamamoto
  • 👤 Masayoshi Kobayashi
  • 👤 Sashichi Okabe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 03:35
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/579; A; A61; A61K; A61K35/00; A61K35/56; A61K35/612

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 242 words
In a process for the preparation of Limulina lysate comprising extracting the blood of horseshoe crabs (Limulina) into an isotonic buffer solution containing an agent which inhibits the agglutination of amebocyte, separating the amebocyte from said solution, breaking the amebocyte, and recovering Limulina lysate, the improvement comprising: (A) the addition of methyl derivatives of xanthine, or the acid addition or alkali salts thereof, having the formula ##EQU2## in which R 1 , R 2 , and R 3 each represent a hydrogen atom or a methyl group, at least one of R 1 , R 2 , and R 3 being a methyl group, as the agglutination-inhibiting agent of the amebocyte, the agglutination-inhibiting agent being present at a concentration of 0.5 to 2 mM in the mixture of the isotonic buffer solution and the blood; with an optional step of (B) further extracting the amebocyte content with 20 to 50 ml, per the amount of amebocyte obtained from 100 ml of the initially extracted blood, of an extraction solvent having a pH of 6.0 to 8.0 and containing at least one alkaline earth metal ion and, optionally, an alkali metal ion, with the provisos that the alkaline earth metal ions are present at a concentration of from 2 to 60 mM and the alkali metal ions are present at a concentration of from 10 to 150 mM, and a further optional step of (C) freeze-drying the so-obtained Limulina lysate containing extraction solution.
Claim 2
Dependent Claim 242 words
In a process for the preparation of Limulina lysate comprising extracting the blood of horseshoe crabs (Limulina) into an isotonic buffer solution containing an agent which inhibits the agglutination of amebocyte, separating the amebocyte from said solution, breaking the amebocyte, and recovering Limulina lysate, the improvement comprising: (A) the addition of methyl derivatives of xanthine, or the acid addition or alkali salts thereof, having the formula ##EQU2## in which R 1 , R 2 , and R 3 each represent a hydrogen atom or a methyl group, at least one of R 1 , R 2 , and R 3 being a methyl group, as the agglutination-inhibiting agent of the amebocyte, the agglutination-inhibiting agent being present at a concentration of 0.5 to 2 mM in the mixture of the isotonic buffer solution and the blood; with an optional step of (B) further extracting the amebocyte content with 20 to 50 ml, per the amount of amebocyte obtained from 100 ml of the initially extracted blood, of an extraction solvent having a pH of 6.0 to 8.0 and containing at least one alkaline earth metal ion and, optionally, an alkali metal ion, with the provisos that the alkaline earth metal ions are present at a concentration of from 2 to 60 mM and the alkali metal ions are present at a concentration of from 10 to 150 mM, and a further optional step of (C) freeze-drying the so-obtained Limulina lysate containing extraction solution.
Claim 3
Dependent Claim 18 words
The process according to claim 1, in which the methyl derivatives of xanthine is theophylline, theobromine, or caffeine.
Claim 4
Dependent Claim 44 words
The process according to claim 1, in which the methyl derivatives of xanthine or the acid addition or alkali salts thereof are used at a concentration of 1 mM in the mixture of the isotonic buffer solution and blood obtained upon the blood extraction.
Claim 5
Dependent Claim 15 words
The process according to claim 1, in which the alkaline earth metal ion is magnesium.
Claim 6
Dependent Claim 20 words
The process according to claim 1, in which the extraction solvent contains alkaline earth metal ions and alkali metal ions.
Claim 7
Dependent Claim 32 words
The process according to claim 5, in which the extraction solvent is an aqueous solution containing 4 mM of calcium ion, 20 mM of magnesium ion, and 40 mM of sodium ion.
Claim 8
Dependent Claim 16 words
The process of claim 1 wherein 30 to 40 ml of the extraction solvent is added.
Claim 9
Dependent Claim 19 words
The process of claim 4 wherein the magnesium ion is present at a concentration of 5 to 50 mM.
Claim 10
Dependent Claim 17 words
The process of claim 8 wherein the magnesium ion is present at a concentration of 20 mM.
Claim 11
Dependent Claim 13 words
The process of claim 1 wherein the alkaline earth metal ion is calcium.
Claim 12
Dependent Claim 19 words
The process of claim 10 wherein the calcium ion is present at a concentration of 2 to 10 mM.
Claim 13
Dependent Claim 17 words
The process of claim 11 wherein the calcium ion is present at a concentration of 4 mM.
Claim 14
Dependent Claim 20 words
The process of claim 5 wherein the alkali metal ion is sodium ion present at a concentration of 40 mM.
Claim 15
Dependent Claim 36 words
The process of claim 5 wherein the extraction solvent is an aqueous solution containing 2 to 10 mM of calcium ion, 5 to 50 mM of magnesium ion, and 10 to 150 mM of sodium ion.
Claim 16
Dependent Claim 14 words
The extraction solution containing Limulina Lysate prepared according to the process of claim 14.
Claim 17
Dependent Claim 14 words
The extraction solution containing Limulina Lysate prepared according to the process of claim 6.
Claim 18
Dependent Claim 11 words
The process of claim 1 wherein optional step (C) is conducted.
Claim 19
Dependent Claim 22 words
The process of claim 1 in which optional step (B) is conducted and the extraction solvent contains an alkaline earth metal ion.
Claim 20
Dependent Claim 13 words
The freeze-dried powder derived from the Limulina Lysate extraction solution of claim 15.

References Cited (Backward Citations)

US3729947A Cited
US3740433A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-05-04 1979-11-03 1980-05-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-05-04 1983-11-03 1984-05-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-05-04 1987-11-03 1988-05-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag